Class IITerminatedD-1055-2014
Drug recall · February 12, 2014
Dicopanol FusePaq Kit for Oral Suspension recall
Why: Microbial Contamination of Non-Sterile Products: Fusion Pharmaceuticals is recalling the Dicopanol FusePaq Kit due to Total Yeasts and Molds Count above USP limits.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dicopanol FusePaq Kit for Oral Suspension, 5mg/ML
- Lots / codes
Lots: PL520, PL521, PL522 and PL523
- Quantity
- 1,200 kits
- Company
- Fusion Pharmaceuticals, LLC, Camarillo, CA
- Distribution
- CA
- Initiated
- May 8, 2013 · Voluntary: Firm initiated
- Classified
- January 31, 2014
- Reported
- February 12, 2014
- Ended
- January 31, 2014
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.